Evidence map›Paper›PMID 37234365›Full record

ArticleAdvanced nanobiomed research2023

Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasis.

Trisha M Westerhof, Benjamin A Yang, Nathan M Merill, Joel A Yates, Megan Altemus, Liam Russell, Anna J Miller, Liwei Bao, Zhifen Wu, Peter J Ulintz and 5 more

Open access · goldAbstract read
In one paragraph

Article in Advanced nanobiomed research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Modular cone-and-plate device for mechanofluidic assays in Transwell inserts.Frontiers in bioengineering and biotechnology · 2025
    Article
  9. Advances in gut-brain organ chips.Cell proliferation · 2024
    Review
  10. Tumor-on-chip platforms for breast cancer continuum concept modeling.Frontiers in bioengineering and biotechnology · 2024
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Trisha M WesterhofMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Benjamin A YangSchool of Engineering, Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Nathan M MerillMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Joel A YatesMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Megan AltemusMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Liam RussellSchool of Engineering, Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Anna J MillerSchool of Engineering, Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Liwei BaoMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Zhifen WuMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Peter J UlintzMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Carlos A AguilarSchool of Engineering, Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Aki MorikawaMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Maria G CastroMichigan Medicine, Department of Neurosurgery, University of Michigan, Ann Arbor, MI 48109, USA.
Sofia D MerajverMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Christopher R OliverMichigan Medicine, Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
Stem Cell Differentiation CoreU19AI116482 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPENCE, JASON, TAKAYAMA, SHUICHI · 2015 to 2019
$6.4M
Systems Bioengineering of Cancer Cell MigrationR01CA196018 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDERMAN, JENNIFER JEAN, LUKER, GARY D · 2015 to 2019
$2.2M
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligenceR33CA261696 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FU, JIANPING, MERAJVER, SOFIA DIANA · 2022 to 2024
$1.1M
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosisR21CA245597 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MERAJVER, SOFIA DIANA · 2020 to 2021
$401k
NCATS NIH HHS UL1 TR002240NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA196018NCI NIH HHS R21 CA245597NCI NIH HHS R33 CA261696NCI NIH HHS T32 CA009676NIAID NIH HHS U19 AI116482
6 · The paper itself

Abstract

Brain metastases are the most lethal progression event, in part because the biological processes underpinning brain metastases are poorly understood. There is a paucity of realistic models of metastasis, as current

Indexed as

blood brain barriercancerdkk-1metabolitesmetastasismicroenvironmentmicrofluidicsecretionssecretome

Identifiers

PMID37234365
PMCPMC10208594
OpenAlexW4319264634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.